[Prognostic value, clinical effectiveness and cost-effectiveness of high sensitivity C-reactive protein as a marker in primary prevention of major cardiac events]
Schnell-Inderst P, Schwarzer R, Goehler A, Grandi N, Grabein K, Stollenwerk B, Klauss V, Wasem J, Siebert U
Record ID 32006001202
German
Details
Project Status:
Completed
URL for project:
http://portal.dimdi.de/de/hta/hta_berichte/hta216_summary_en.pdf
Year Published:
2009
URL for published report:
http://portal.dimdi.de/de/hta/hta_berichte/hta216_bericht_de.pdf
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Germany
MeSH Terms
- Risk Factors
- Biomarkers
- C-Reactive Protein
- Myocardial Infarction
Contact
Organisation Name:
German Agency for HTA at the German Institute for Medical Documentation and Information
Contact Address:
German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information, Waisenhausgasse 36-38a, D-50676 Cologne Germany
Contact Name:
dahta@dimdi.de
Contact Email:
dahta@dimdi.de
Copyright:
German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA@DIMDI)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.